Vice President, Sales

Role Summary

Kyverna Therapeutics is a patient-focused, clinical-stage biotechnology company advancing cell therapies for people living with autoimmune disease. The company is driven by values centered on purpose, collaboration, clarity, innovation, and accountability, and is working to reshape the future of autoimmune treatment.

This leadership role is responsible for designing and executing the U.S. commercial sales and go-to-market strategy for a first-in-class CAR-T therapy portfolio. The Vice President of Sales will build and scale a strong specialty sales organization, support successful launches, deepen market reach, and strengthen customer relationships across academic medical centers, integrated delivery networks, community neurology practices, and specialized treatment sites.

The position suits a senior commercial leader with a strong background in rare disease, neurology, cell and gene therapy, oncology, immunology, or similarly specialized therapeutic areas. Success in this role requires launch leadership, account-based selling expertise, treatment-center engagement capability, and a solid grasp of reimbursement and site-of-care complexity.

Role Details

Department: Commercial

Work Location: Remote within the United States

Reporting Line: Chief Commercial Officer

Key Responsibilities

The role covers strategy creation, field organization leadership, CAR-T commercialization, neurology market engagement, cross-functional partnership, and performance management.

• Create and implement the U.S. sales plan supporting commercialization of CAR-T therapies for autoimmune disease.
• Build, scale, and guide a top-tier specialty sales team that can support both current and future launches.
• Define commercial goals, territory structure, targeting approach, and field deployment models that match broader company objectives.
• Grow revenue while maintaining full compliance with regulatory, legal, and internal policies.
• Work with senior leadership to shape long-range commercial direction and portfolio strategy.
• Lead commercialization across the CAR-T ecosystem, including treatment centers, referring physicians, infusion locations, and hospital systems.
• Develop approaches that improve treatment-center activation, patient finding, referral flow, and patient access.
• Partner with Market Access, Cell Therapy Operations, Patient Services, and Medical Affairs to support smooth therapy adoption.
• Address operational complexity tied to cell collection, manufacturing, logistics, reimbursement, and site preparedness.
• Track market changes, competitor activity, and new therapy trends in the CAR-T landscape.
• Build relationships with key neurology stakeholders such as academic centers, neuroscience programs, and community neurologists.
• Shape engagement strategies for autoimmune neurological disorders, neurodegenerative diseases, and other complex neurological conditions.
• Create disease-state education and value-based customer engagement programs.
• Coordinate with Medical Affairs to support scientific exchange and customer education efforts.
• Recruit, develop, and retain strong regional sales leaders and field sales professionals.
• Create a performance-driven culture rooted in accountability, teamwork, innovation, and patient impact.
• Set expectations, coaching frameworks, succession plans, and talent-development programs.
• Lead training in disease knowledge, clinical evidence, reimbursement, and customer engagement excellence.
• Collaborate with Market Access, Medical Affairs, Marketing, Commercial Operations, Patient Services, Legal, Compliance, and Finance.
• Align field activity with broader commercial strategy.
• Support forecasting, business planning, resource allocation, and launch-readiness work.
• Bring field insights back to inform brand strategy, lifecycle planning, and evidence-generation priorities.
• Define and monitor KPIs covering sales performance, account engagement, treatment-center activation, patient referrals, and market penetration.
• Use data and analytics to improve territory performance and resource deployment.
• Present regular business reviews and strategic recommendations to executive leadership.
• Identify opportunities to strengthen commercial effectiveness and improve customer experience.

Qualifications

• A bachelor’s degree is required; an advanced degree such as an MBA, PharmD, PhD, or another relevant graduate credential is preferred.
• At least 15 years of biopharmaceutical commercial experience is required.
• At least 8 years of progressive sales leadership experience is required, including leadership of national specialty sales teams.
• Successful history of launching and commercializing specialty, rare disease, neurology, oncology, immunology, or cell and gene therapy products.
• Strong understanding of specialty reimbursement, payer dynamics, treatment-center engagement, and patient access.
• Experience leading field teams that support highly complex therapies and specialized provider networks.
• Demonstrated ability to build, lead, and expand high-performing commercial organizations.

Preferred Background

• Direct experience with CAR-T, cell therapy, gene therapy, or oncology commercialization.
• Neurology commercialization experience, especially in autoimmune or rare neurological conditions.
• Experience launching products through limited distribution models and specialized treatment centers.
• Working knowledge of buy-and-bill reimbursement, specialty pharmacy, specialty distribution, and site-of-care planning.

Compensation and Benefits

The annual base salary range for this role is estimated at USD 300,000 to USD 340,000. Actual pay may differ depending on education, experience, tenure, skills, abilities, internal pay alignment, and market conditions. The position is also eligible for bonus compensation, benefits, and participation in the company stock plan.